RE:800k doctors in the U.S and 80k in CanadaNailbiter1 wrote: I'm not sure what the medical target group is with these blood screens. G.P.(family doctors) or specialists in the fields of mammography, oncology, hematology, proctology, pulmonary... The G.P.'s far outnumber the specialists. this would have a considerable impact on the numbers. I've been looking for that info but can't seem to find it. Because of my abnormal schedule, I can't commit to attending the live video conferences offered by the company CEO. He would be the one to know. Either way, just the fact that interest seems to gaining momentum with investors is a positive sign. An oncologist in Ottawa that I spoke with recently is invested in GEN and has strong conviction that it is a powerful tool in an arsenal of new cancer sciences that will save many lives. When it's backed by the pros, that's good enough for me.
The GPS are usually in charge of prescribing these early detection tests, at least this the case for colonoscopies and prostate PSA tests (and mammographies?). One should not forget either that early detection usually involves retesting the same patients at regular intervals past a certain age or if you are part of an at-risk group. So, for example, the same 10000 clients might be retested twice or thrice in their lifetimes... plus the yearly crop of new clients. It all works like cou,pound interest. The potential is truly huge!
MoriaDwarf